Home/Filings/4/0001179110-14-000951
4//SEC Filing

ABIOMED INC 4

Accession 0001179110-14-000951

CIK 0000815094operating

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:13 PM ET

Size

18.6 KB

Accession

0001179110-14-000951

Insider Transaction Report

Form 4
Period: 2014-01-10
Bowen Robert
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-107,5007,500 total
    Exercise: $10.03From: 2011-06-03Exp: 2020-06-03Common Stock (7,500 underlying)
  • Exercise/Conversion

    Common Stock, $.01 par value

    2014-01-10$5.86/sh+30,000$175,80096,929 total
  • Exercise/Conversion

    Common Stock, $.01 par value

    2014-01-10$10.03/sh+7,500$75,225104,429 total
  • Sale

    Common Stock, $.01 par value

    2014-01-10$30.00/sh37,500$1,125,00066,929 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-1030,0000 total
    Exercise: $5.86From: 2010-03-31Exp: 2019-05-28Common Stock (30,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $15.92From: 2009-12-22Exp: 2018-12-22Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $22.44From: 2013-05-22Exp: 2022-05-22Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy)

    Exercise: $23.15From: 2014-05-14Exp: 2024-05-14Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
  • [F3]Sale of common stock pursuant to reporting owner's 10b5-1 plan.

Issuer

ABIOMED INC

CIK 0000815094

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000815094

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:13 PM ET
Size
18.6 KB